As of Sep 30
| +0.20 / +3.77%|
The 5 analysts offering 12-month price forecasts for Synergy Pharmaceuticals Inc have a median target of 11.00, with a high estimate of 15.00 and a low estimate of 4.00. The median estimate represents a +99.64% increase from the last price of 5.51.
The current consensus among 5 polled investment analysts is to Buy stock in Synergy Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.